CC(C)[C@H](NC(=O)c1ccco1)C(=O)OCc1cc(=O)n2c(n1)sc1ccccc12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?